+

WO1999019358A3 - Anticorps agissant a l'encontre de baculovirus - Google Patents

Anticorps agissant a l'encontre de baculovirus Download PDF

Info

Publication number
WO1999019358A3
WO1999019358A3 PCT/DE1998/003036 DE9803036W WO9919358A3 WO 1999019358 A3 WO1999019358 A3 WO 1999019358A3 DE 9803036 W DE9803036 W DE 9803036W WO 9919358 A3 WO9919358 A3 WO 9919358A3
Authority
WO
WIPO (PCT)
Prior art keywords
baculoviruses
antibody against
antibodies
relates
kit
Prior art date
Application number
PCT/DE1998/003036
Other languages
German (de)
English (en)
Other versions
WO1999019358B1 (fr
WO1999019358A2 (fr
Inventor
Sara Mariani
Peter Krammer
Original Assignee
Deutsches Krebsforsch
Sara Mariani
Peter Krammer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Deutsches Krebsforsch, Sara Mariani, Peter Krammer filed Critical Deutsches Krebsforsch
Publication of WO1999019358A2 publication Critical patent/WO1999019358A2/fr
Publication of WO1999019358A3 publication Critical patent/WO1999019358A3/fr
Publication of WO1999019358B1 publication Critical patent/WO1999019358B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/01—DNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

L'invention concerne des anticorps agissant à l'encontre de baculovirus, notamment des baculovirus recombinés. L'invention concerne en outre des procédés permettant de préparer lesdits anticorps et un kit les contenant, ainsi que l'utilisation desdits anticorps et respectivement du kit.
PCT/DE1998/003036 1997-10-09 1998-10-09 Anticorps agissant a l'encontre de baculovirus WO1999019358A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE1997144655 DE19744655C2 (de) 1997-10-09 1997-10-09 Antikörper gegen Baculoviren
DE19744655.8 1997-10-09

Publications (3)

Publication Number Publication Date
WO1999019358A2 WO1999019358A2 (fr) 1999-04-22
WO1999019358A3 true WO1999019358A3 (fr) 1999-06-17
WO1999019358B1 WO1999019358B1 (fr) 1999-07-22

Family

ID=7845075

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DE1998/003036 WO1999019358A2 (fr) 1997-10-09 1998-10-09 Anticorps agissant a l'encontre de baculovirus

Country Status (2)

Country Link
DE (1) DE19744655C2 (fr)
WO (1) WO1999019358A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0013561D0 (en) * 2000-06-02 2000-07-26 Glaxo Group Ltd Assay

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
MARIANI, SARA M. ET AL: "Detection of active infection of Sf9 insect cells by recombinant baculoviruses", J. VIROL. METHODS (DECEMBER 1997), 69(1,2), 19-28 CODEN: JVMEDH;ISSN: 0166-0934, XP002095592 *
MCCARTHY, W. J. ET AL: "Current developments in baculovirus serology", BIOL. BACULOVIRUSES (1986), VOLUME 1, 147-58. EDITOR(S): GRANADOS, ROBER R.;FEDERICI, BRIAN A. PUBLISHER: CRC, BOCA RATON, FLA. CODEN: 55ZFA2, XP002095588 *
OOMENS, A. G. P. ET AL: "The baculovirus GP64 envelope fusion protein: synthesis, oligomerization, and processing", VIROLOGY (1995), 209(2), 592-603 CODEN: VIRLAX;ISSN: 0042-6822, XP002095591 *
SLACK, JEFFREY M. ET AL: "Characterization of v - cath, a cathepsin L-like proteinase expressed by the baculovirus Autographa californica multiple nuclear polyhedrosis virus", J. GEN. VIROL. (1995), 76(5), 1091-8 CODEN: JGVIAY;ISSN: 0022-1317, XP002095590 *
WHITFORD, MARC ET AL: "Identification and sequence analysis of a gene encoding gp67, an abundant envelope glycoprotein of the baculovirus Autographa californica nuclear polyhedrosis virus", J. VIROL. (1989), 63(3), 1393-9 CODEN: JOVIAM;ISSN: 0022-538X, XP002095589 *

Also Published As

Publication number Publication date
DE19744655C2 (de) 2000-03-16
WO1999019358B1 (fr) 1999-07-22
DE19744655A1 (de) 1999-04-15
WO1999019358A2 (fr) 1999-04-22

Similar Documents

Publication Publication Date Title
AU5665696A (en) Novel methods for the assay of troponin i and t and complexe s of troponin i and t and selection of antibodies for use in immunoassays
AU1704099A (en) Monoclonal human natural antibodies
WO2002030986A3 (fr) ANTICORPS HUMANISES ANTI-LT-β-R
WO1999062526A3 (fr) Traitement du myelome multiple au moyen d'anticorps du cd38 obtenus par genie genetique
GEP20105118B (en) Anti-vegf antibodies
BR9810654B8 (pt) mÉtodo de preparaÇço de um polipeptÍdeo, molÉculas de anticorpo e composiÇço.
WO2001070984A3 (fr) Anticorps de facteur anti-tissulaire a pouvoir anticoagulant ameliore
AU5869596A (en) Anti-gp130 monoclonal antibodies
AU2455295A (en) Protein or polypeptide, process for producing the same, and intermediate compound tehrefor
AUPN999096A0 (en) Peptides, antibodies, vaccines & uses thereof
WO1996027665A3 (fr) Proteines ayant les proprietes d'un facteur silenceur exerçant une action de repression sur les neurones
WO2000015798A3 (fr) Facteur de croissance transformant beta - 9 mammaliens (ztgfss9)
WO1998057983A3 (fr) Proteine de mammifere de type facteur de croissance nerveuse
AU6775894A (en) Atherosclerotic plaque specific antigens, antibodies thereto, and uses thereof
AU7072998A (en) Immunoassays using anti-allotypic monoclonal antibodies
AU2547995A (en) Monoclonal antibody specific for vascular endothelial cell antigen endoglyx-1, the antigen itself, and uses thereof
WO1999019358A3 (fr) Anticorps agissant a l'encontre de baculovirus
WO1999024835A3 (fr) Immuno-essai pour propeptide de procollagene iii a terminal c
GB2279076B (en) Antibodies to fungal antigens
AU2041095A (en) Separation-fee specific binding assays using anti-inhibitor antibodies
WO1999001475A3 (fr) Anticorps humain diriges contre un (poly)peptide ou une proteine hybride comportant une partie presentant au moins six histidines
AU7478098A (en) Methods of treatment using nbs-1, antibodies and proteins thereto, and uses of the antibodies
AU2169797A (en) Improved production of antibodies through the use of antigen antibody complexes
AU2793297A (en) Anti-human lect2 antibody, cells producing the same, and method and kit for assaying the same
WO1998024894A3 (fr) Fragments pkd1 a sites de liaison pour anticorps specifiques de pkd1

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

AK Designated states

Kind code of ref document: A3

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: B1

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: B1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

122 Ep: pct application non-entry in european phase
点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载